Aktiia Scores $42M for Next-Gen Blood Pressure Tech
Rebranding as Hilo, the Swiss company will scale its “blood pressure intelligence” to the US this year, following expected FDA approval.
Read More from the Global Wellness News ™
Aktiia Scores $42M for Next-Gen Blood Pressure Tech
Rebranding as Hilo, the Swiss company will scale its “blood pressure intelligence” to the US this year, following expected FDA approval.
Read More from the Global Wellness News ™